about
Aspergillus fumigatus-Related Species in Clinical PracticeVariable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia.Calcineurin as a Multifunctional Regulator: Unraveling Novel Functions in Fungal Stress Responses, Hyphal Growth, Drug Resistance, and PathogenesisCalcineurin-mediated regulation of hyphal growth, septation, and virulence in Aspergillus fumigatus.Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis.Identification and mutational analyses of phosphorylation sites of the calcineurin-binding protein CbpA and the identification of domains required for calcineurin binding in Aspergillus fumigatusAntifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.Calcium-Mediated Induction of Paradoxical Growth following Caspofungin Treatment Is Associated with Calcineurin Activation and Phosphorylation in Aspergillus fumigatus.Hsp70 and the Cochaperone StiA (Hop) Orchestrate Hsp90-Mediated Caspofungin Tolerance in Aspergillus fumigatus.The Aspergillus fumigatus septins play pleiotropic roles in septation, conidiation, and cell wall stress, but are dispensable for virulence.Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold InfectionsReassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignanciesPopulation pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovirLow-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.Transcriptional activation of heat shock protein 90 mediated via a proximal promoter region as trigger of caspofungin resistance in Aspergillus fumigatusAmoebal pathogens as emerging causal agents of pneumonia.Fastidious intracellular bacteria as causal agents of community-acquired pneumonia.Immunogenetics of invasive aspergillosis.Waddlia: An emerging pathogen and a model organism to study the biology of chlamydiae.[Diagnostic approach of intracellular bacteria and fastidious microorganisms].ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.Nonmolecular methods for the diagnosis of respiratory fungal infections.Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.Early diagnosis of invasive mould infections and disease.Potential Microbiological Effects of Higher Dosing of Echinocandins.Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.[A 25-year-old woman with fever and hepatosplenomegaly: diagnostic approach]Editorial: Advances in Aspergillus fumigatus Pathobiology.Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species.Heat shock protein 90 is required for conidiation and cell wall integrity in Aspergillus fumigatus.Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients*.β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.Parachlamydia and rhabdochlamydia in premature neonates.Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection.
P50
Q26744684-56001492-2693-4894-A193-CEFE9437A6BDQ33522300-F9453068-1A97-43E1-BCEE-0B1421F43508Q33622943-1CD12867-E7B1-42CA-BF54-6DEA72C205B4Q33889170-CB43FAB8-BDBC-4E36-B413-DAFB618AA842Q34150967-64A0A2F4-E353-4565-BA98-7C5FBBA38A68Q34190425-B2268479-A68D-4F1A-9ED0-6E95AD327389Q34449662-699A2EB6-41D1-481F-84EC-C9D157780BC0Q34550577-B2C8EED8-D9ED-4234-AE91-E990452B95C5Q35087299-4836805F-B55C-4A10-94C5-C5A6613E4FD0Q35172855-12443156-8901-4ADC-9971-9AF3B11F0A49Q35746106-A8C26E6D-F7B5-4CB2-8BC5-27751B2B24D0Q35860027-CF4E543D-39C7-47FB-B785-A4A1EE554DACQ35860061-E9CC2106-8B0D-43D7-A71F-E309BF5B8318Q35901122-D9E2D5AC-84C4-45AC-8E55-CC6FD7A648F7Q36066784-19F4E7CA-E49B-49C8-B9B5-4BFEBDCF96E6Q36558376-8F2E3645-7F3F-4FF6-BB3D-BFFEDC5CAA52Q36933186-11704571-5B73-40D7-8A2B-D8598274F617Q37072039-F27103DC-E326-49F0-B53E-F736C1E9C3FFQ37247594-6AE7C27F-8439-43BD-B9B8-DE84A5DD783FQ37385998-298A5557-F847-4138-9703-0930C3B60C5CQ37443093-76D11DF2-71CB-4373-9D92-C2C023DF0952Q37683796-89CF9545-EB17-435E-890C-24ACE241DC77Q37768416-8E7252BD-0F95-405A-BBA1-C76B86AF8E55Q37788693-F997CB04-53B7-46E8-AAF8-7CE6125D0C3CQ37838856-7B496E14-6D53-4477-B24B-7026EC2D47D0Q37842380-E2304BA1-9103-4459-B25A-39DBBD85F9F9Q37934487-20C310F1-0C4E-4464-AF10-072621030470Q38214189-5FB30608-700A-4139-87E7-70359653C876Q38253077-D537D7A6-4E69-4568-A0C4-758CB2CBD32BQ38738085-563D39C4-9913-4EFC-B0DD-882C99F4E8BAQ38942828-61A37680-2F95-4DD4-BD6C-F1EDAB73A08BQ38960267-DA8B7A1C-46AF-4F27-BF08-C964F515E71AQ40473174-A72A9630-1495-4169-83B7-3FEBA716D6A9Q40794362-EEDE2B3D-1728-44ED-9E54-CE8DFB28FCC4Q41564163-34C58ED1-C4F6-4F89-B9E9-ECE662678A80Q41585535-CBAAF97B-B758-43F3-8C9E-7EB4E0AA3E40Q42227547-61147198-6EDD-48F6-921E-46F2C4C8EA1DQ42258343-81D39804-EA21-4C63-9CE5-2132C245BD46Q42630511-F8F77D71-78DF-49EC-B86B-9DC6A51EE394Q43019627-B756D5E6-2A7A-4737-B062-80298A2C852F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Frédéric Lamoth
@ast
Frédéric Lamoth
@en
Frédéric Lamoth
@es
Frédéric Lamoth
@sl
type
label
Frédéric Lamoth
@ast
Frédéric Lamoth
@en
Frédéric Lamoth
@es
Frédéric Lamoth
@sl
prefLabel
Frédéric Lamoth
@ast
Frédéric Lamoth
@en
Frédéric Lamoth
@es
Frédéric Lamoth
@sl
P1053
K-6454-2017
P106
P21
P31
P3829
P496
0000-0002-1023-5597